LAMEA Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025
The Latin America, Middle East and Africa Tumor Ablation Market would witness market growth of 13.2% CAGR during the forecast period (2019-2025).
The ablation market for tumors in the Middle East & Africa is fueled by factors such as the growing aging population and the increased number of people suffering from cancer. An increase in the demand for minimally invasive cancer treatment procedures and high awareness of the benefits that ablation procedures offer over conventional surgical procedures are also among the key factors that add up to market growth.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
The ablation market for tumors in the Middle East & Africa is fueled by factors such as the growing aging population and the increased number of people suffering from cancer. An increase in the demand for minimally invasive cancer treatment procedures and high awareness of the benefits that ablation procedures offer over conventional surgical procedures are also among the key factors that add up to market growth.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation and
- Other Technology
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Tumor Ablation Market, by Treatment
1.4.2 LAMEA Tumor Ablation Market, by Technology
1.4.3 LAMEA Tumor Ablation Market, by Application
1.4.4 LAMEA Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. LAMEA TUMOR ABLATION MARKET BY TREATMENT
4.1 LAMEA Surgical Ablation Market by Country
4.2 LAMEA Laparoscopic Ablation Market by Country
4.3 LAMEA Percutaneous Ablation Market by Country
CHAPTER 5. LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 LAMEA Radiofrequency Ablation Market by Country
5.2 LAMEA Microwave Ablation Market by Country
5.3 LAMEA Cryoablation Market by Country
5.4 LAMEA Irreversible Electroporation Market by Country
5.5 LAMEA Other Technology Market by Country
CHAPTER 6. LAMEA TUMOR ABLATION MARKET BY APPLICATION
6.1 LAMEA Liver Cancer Market by Country
6.2 LAMEA Breast Cancer Market by Country
6.3 LAMEA Lung Cancer Market by Country
6.4 LAMEA Kidney Cancer Market by Country
6.5 LAMEA Prostate Cancer Market by Country
6.6 LAMEA Other Cancer Market by Country
CHAPTER 7. LAMEA TUMOR ABLATION MARKET BY COUNTRY
7.1 Brazil Tumor Ablation Market
7.1.1 Brazil Tumor Ablation Market by Treatment
7.1.2 Brazil Tumor Ablation Market by Technology
7.1.3 Brazil Tumor Ablation Market by Application
7.2 Argentina Tumor Ablation Market
7.2.1 Argentina Tumor Ablation Market by Treatment
7.2.2 Argentina Tumor Ablation Market by Technology
7.2.3 Argentina Tumor Ablation Market by Application
7.3 UAE Tumor Ablation Market
7.3.1 UAE Tumor Ablation Market by Treatment
7.3.2 UAE Tumor Ablation Market by Technology
7.3.3 UAE Tumor Ablation Market by Application
7.4 Saudi Arabia Tumor Ablation Market
7.4.1 Saudi Arabia Tumor Ablation Market by Treatment
7.4.2 Saudi Arabia Tumor Ablation Market by Technology
7.4.3 Saudi Arabia Tumor Ablation Market by Application
7.5 South Africa Tumor Ablation Market
7.5.1 South Africa Tumor Ablation Market by Treatment
7.5.2 South Africa Tumor Ablation Market by Technology
7.5.3 South Africa Tumor Ablation Market by Application
7.6 Nigeria Tumor Ablation Market
7.6.1 Nigeria Tumor Ablation Market by Treatment
7.6.2 Nigeria Tumor Ablation Market by Technology
7.6.3 Nigeria Tumor Ablation Market by Application
7.7 Rest of LAMEA Tumor Ablation Market
7.7.1 Rest of LAMEA Tumor Ablation Market by Treatment
7.7.2 Rest of LAMEA Tumor Ablation Market by Technology
7.7.3 Rest of LAMEA Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Tumor Ablation Market, by Treatment
1.4.2 LAMEA Tumor Ablation Market, by Technology
1.4.3 LAMEA Tumor Ablation Market, by Application
1.4.4 LAMEA Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. LAMEA TUMOR ABLATION MARKET BY TREATMENT
4.1 LAMEA Surgical Ablation Market by Country
4.2 LAMEA Laparoscopic Ablation Market by Country
4.3 LAMEA Percutaneous Ablation Market by Country
CHAPTER 5. LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 LAMEA Radiofrequency Ablation Market by Country
5.2 LAMEA Microwave Ablation Market by Country
5.3 LAMEA Cryoablation Market by Country
5.4 LAMEA Irreversible Electroporation Market by Country
5.5 LAMEA Other Technology Market by Country
CHAPTER 6. LAMEA TUMOR ABLATION MARKET BY APPLICATION
6.1 LAMEA Liver Cancer Market by Country
6.2 LAMEA Breast Cancer Market by Country
6.3 LAMEA Lung Cancer Market by Country
6.4 LAMEA Kidney Cancer Market by Country
6.5 LAMEA Prostate Cancer Market by Country
6.6 LAMEA Other Cancer Market by Country
CHAPTER 7. LAMEA TUMOR ABLATION MARKET BY COUNTRY
7.1 Brazil Tumor Ablation Market
7.1.1 Brazil Tumor Ablation Market by Treatment
7.1.2 Brazil Tumor Ablation Market by Technology
7.1.3 Brazil Tumor Ablation Market by Application
7.2 Argentina Tumor Ablation Market
7.2.1 Argentina Tumor Ablation Market by Treatment
7.2.2 Argentina Tumor Ablation Market by Technology
7.2.3 Argentina Tumor Ablation Market by Application
7.3 UAE Tumor Ablation Market
7.3.1 UAE Tumor Ablation Market by Treatment
7.3.2 UAE Tumor Ablation Market by Technology
7.3.3 UAE Tumor Ablation Market by Application
7.4 Saudi Arabia Tumor Ablation Market
7.4.1 Saudi Arabia Tumor Ablation Market by Treatment
7.4.2 Saudi Arabia Tumor Ablation Market by Technology
7.4.3 Saudi Arabia Tumor Ablation Market by Application
7.5 South Africa Tumor Ablation Market
7.5.1 South Africa Tumor Ablation Market by Treatment
7.5.2 South Africa Tumor Ablation Market by Technology
7.5.3 South Africa Tumor Ablation Market by Application
7.6 Nigeria Tumor Ablation Market
7.6.1 Nigeria Tumor Ablation Market by Treatment
7.6.2 Nigeria Tumor Ablation Market by Technology
7.6.3 Nigeria Tumor Ablation Market by Application
7.7 Rest of LAMEA Tumor Ablation Market
7.7.1 Rest of LAMEA Tumor Ablation Market by Treatment
7.7.2 Rest of LAMEA Tumor Ablation Market by Technology
7.7.3 Rest of LAMEA Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
LIST OF TABLES
TABLE 1 LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 LAMEA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 LAMEA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 LAMEA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 LAMEA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 LAMEA OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 LAMEA OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 BRAZIL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 BRAZIL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 ARGENTINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 ARGENTINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 UAE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 UAE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 UAE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 UAE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 UAE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 UAE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 SAUDI ARABIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 SAUDI ARABIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 SOUTH AFRICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 75 SOUTH AFRICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 76 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 77 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 78 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 79 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 80 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 81 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 82 NIGERIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 83 NIGERIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 84 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 85 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 86 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 87 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 88 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 89 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 90 REST OF LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 91 REST OF LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 92 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 93 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 94 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 95 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 96 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 97 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 98 KEY INFORMATION – MEDTRONIC PLC
TABLE 99 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 100 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 101 KEY INFORMATION – MISONIX, INC.
TABLE 102 KEY INFORMATION – EDAP TMS S.A.
TABLE 103 KEY INFORMATION – THERACLION SA
TABLE 104 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 105 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 106 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 107 KEY INFORMATION – SONACARE MEDICAL, LLC
TABLE 1 LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 LAMEA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 LAMEA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 LAMEA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 LAMEA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 LAMEA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 LAMEA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 LAMEA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 LAMEA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 LAMEA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 LAMEA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 LAMEA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 LAMEA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 LAMEA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 LAMEA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 LAMEA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 LAMEA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 LAMEA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 LAMEA OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 LAMEA OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 LAMEA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 BRAZIL TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 BRAZIL TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 BRAZIL TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 BRAZIL TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 BRAZIL TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 ARGENTINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 ARGENTINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 ARGENTINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 ARGENTINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 ARGENTINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 UAE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 UAE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 UAE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 UAE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 UAE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 UAE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 UAE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 SAUDI ARABIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 SAUDI ARABIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 SAUDI ARABIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 SAUDI ARABIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 SAUDI ARABIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 SOUTH AFRICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 75 SOUTH AFRICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 76 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 77 SOUTH AFRICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 78 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 79 SOUTH AFRICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 80 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 81 SOUTH AFRICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 82 NIGERIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 83 NIGERIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 84 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 85 NIGERIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 86 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 87 NIGERIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 88 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 89 NIGERIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 90 REST OF LAMEA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 91 REST OF LAMEA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 92 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 93 REST OF LAMEA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 94 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 95 REST OF LAMEA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 96 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 97 REST OF LAMEA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 98 KEY INFORMATION – MEDTRONIC PLC
TABLE 99 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 100 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 101 KEY INFORMATION – MISONIX, INC.
TABLE 102 KEY INFORMATION – EDAP TMS S.A.
TABLE 103 KEY INFORMATION – THERACLION SA
TABLE 104 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 105 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 106 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 107 KEY INFORMATION – SONACARE MEDICAL, LLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
